F104 Rheum-Derm Conditions for the General Dermatologist
DESCRIPTION
This course is designed to help general dermatologists recognize skin manifestations of rheumatologic diseases in their everyday practices. Learners will be able to formulate a plan including further orders/investigations needed and first line treatments.
LEARNING OBJECTIVES
Recognize the most common dermatological findings in rheumatologic diseases including differentiating between cutaneous lupus and dermatomyositis
Complete necessary further workup for skin findings in rheumatologic diseases
Select the best treatments for the skin findings in rheumatologic diseases
SCHEDULE
3:30 PM
Mimickers of the Rheumatological Skin Diseases for the General Dermatologist
Katharina Stephanie Shaw, MD, FAAD
4:00 PM
Clinical Pearls for Sarcoidosis Diagnosis and Management
Christopher T Richardson, PhD, MD, FAAD
4:30 PM
Differences between the different Rheum/Derm Diseases
Alisa Femia, MD, FAAD
5:00 PM
Everyday Management Tips for Rheumatologic Skin Diseases
Lauren V. Graham, MD, PhD, FAAD
DIRECTOR
Lauren V. Graham, MD, PhD, FAAD
SPEAKERS
Alisa Femia, MD, FAAD
Christopher T Richardson, PhD, MD, FAAD
Katharina Stephanie Shaw, MD, FAAD
DISCLOSURES
Alisa Femia, MD, FAAD
Astra Zeneca – Consultant (1099 relationship)(Honoraria); Biogen – Advisory Board(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); EMD Serono – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Veradermics – Consultant (1099 relationship)(Honoraria);
Lauren V. Graham, MD, PhD, FAAD
arGEN-X – Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Fees); Biogen – Investigator(Grants/Research Funding); clarivate – Consultant (1099 relationship)(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding);
Christopher T Richardson, PhD, MD, FAAD
AstraZeneca – Investigator(Grants/Research Funding); Biogen – Advisory Board(Fees); Incyte Corporation – Investigator(Grants/Research Funding); Merck – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); Priovant – Investigator(Grants/Research Funding); Priovant Therapeutics – Advisory Board(Fees);
Katharina Stephanie Shaw, MD, FAAD
Priovant – Employee (w-2 relationship)(Salary);